NCT06748118 Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals.
| NCT ID | NCT06748118 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Chronic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,210 participants |
| Start Date | 2026-03-18 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,210 participants in total. It began in 2026-03-18 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare professionals during consultations/interviews Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action concerning therapeutic adherence. This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake.
Eligibility Criteria
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Affiliated to the French social security system * Followed in hospital for a chronic pathology within a formalized care pathway * Having signed a consent form to participate in the study. Exclusion Criteria: * Patients included in the control period. * Patients under guardianship. * Pregnant or breast-feeding patients. * Patients taking part in research on compliance
Contact & Investigator
Brigitte SABATIER, Dr
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT06748118 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06748118 currently recruiting?
Yes, NCT06748118 is actively recruiting participants. Contact the research team at tiffany.martin@aphp.fr for enrollment information.
Where is the NCT06748118 trial being conducted?
This trial is being conducted at Angers, France, Antibes, France, Issy-les-Moulineaux, France, Marseille, France and 6 additional locations.
Who is sponsoring the NCT06748118 clinical trial?
NCT06748118 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Brigitte SABATIER, Dr at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 1,210 participants.